INSIGHTS ON DRUG DEVELOPMENT
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
Improve Bioanalysis Workflows With Integrated Technologies
Improve bioanalysis workflows with integrated technologies designed for sensitive biomolecules. Explore how biocompatible systems can support sample integrity, reliable performance, and evolving needs.
-
Automated Testing For Compound Toxicity Effects
Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Assessment Of Compound Toxicity Effects With High-Content Imaging3/17/2025
3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.
-
Patented Process For Intermediates Useful For Etrasimod Arginine3/13/2026
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Developing High Concentration Biopharmaceuticals: Formulation Considerations9/11/2024
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.
-
A Human-Relevant Model Of The Liver Sinusoid11/7/2024
This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
-
Validating Antibodies With Knock-Out Technologies10/8/2024
Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.
DRUG DEVELOPMENT SOLUTIONS
-
Leica DM500 Binocular
Supports a Student Friendly Classroom Environment For Life Science Courses
The Leica DM500 microscope with “plug and play” capability is the ideal tool to make teaching entry-level college and university Life Science courses easy and fun for the instructor and the student.
Student-friendly features such as the pre-focused, pre-centered condenser and the EZTube™ preset diopter, which prevent incorrect adjustments, provide more time for hands-on teaching.
EZStore™ design with integrated handle and cord wrap allows easy carrying, easy lifting and protection against microscope component damage.
-
For workflows where trace contamination can derail sensitivity, consistency matters. See how rigorously tested reagents and isolation chemistries support cleaner controls and more confident results.
-
THUNDER Imager EM Cryo CLEM
In-depth understanding of cellular structural biology
The THUNDER Imager EM Cryo CLEM is a cryo light microscope featuring opto-digital THUNDER technology. It provides the imaging data and secure cryo conditions you need for successful experimental investigations concerning structural biology. Precisely identify cellular structures of interest thanks to high resolution, haze-free imaging with THUNDER technology, then transfer the specimen seamlessly to your EM.
-
Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
-
See how controlled manufacturing, traceability, scalable capacity, and built-in quality checks can reduce risk and support reliable assay workflows, as well as what to look for in a raw material partner.